Magnus Financial Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-3,073
Closed -$255K 291
2022
Q4
$255K Buy
3,073
+110
+4% +$8.91K 0.04% 220
2022
Q3
$235K Sell
2,963
-3,833
-56% -$323K 0.04% 215
2022
Q2
$505K Sell
6,796
-1,811
-21% -$136K 0.09% 146
2022
Q1
$774K Buy
8,607
+6,620
+333% +$611K 0.13% 127
2021
Q4
$222K Sell
1,987
-5,455
-73% -$658K 0.04% 230
2021
Q3
$936K Buy
7,442
+155
+2% +$20K 0.2% 74
2021
Q2
$987K Buy
7,287
+2,289
+46% +$301K 0.22% 72
2021
Q1
$678K Buy
4,998
+515
+11% +$77.1K 0.16% 86
2020
Q4
$631K Buy
4,483
+165
+4% +$21.1K 0.06% 118
2020
Q3
$481K Buy
4,318
+1,695
+65% +$190K 0.06% 131
2020
Q2
$294K Buy
+2,623
New +$258K 0.03% 363

Other funds holding XBI